Trial Profile
Changes in outer retina reflectivity on spectral domain optical coherence tomography (SD-OCT) after intravitreal ocriplasmin in patients with vitreomacular traction with or without macular hole
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Retinal disorders
- Focus Therapeutic Use
- 17 Nov 2015 New trial record